In this systematic review of the literature, we summarized publications on onabotulinumtoxinA injections in adult patients treated for upper- or lower-limb spasticity. Our goal was to review the ...

The majority of the 70 primary studies (comprising 2,163 patients) were conducted in Europe (n = 35) or North America (n = 18), while nine studies were completed in Asia and eight in other geographic ...

What Is Upper Limb Spasticity? Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way ...

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced that the FDA has approved its supplemental biologics application for Botox, or ...

- Revance now expects to report topline results from JUNIPER trial in early 2021 - NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on ...

Allergan announced that the Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Applications (sBLAs) for Botox (onabotulinumtoxinA) injection for the ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced an ...